Waddill William D. 4
4 · Protagonist Therapeutics, Inc · Filed Oct 14, 2025
Insider Transaction Report
Form 4
Waddill William D.
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2025-10-10−12,000→ 0 totalExercise: $6.98Exp: 2028-05-28→ Common Stock (12,000 underlying) - Exercise/Conversion
Common Stock
2025-10-10$6.98/sh+12,000$83,760→ 17,130 total - Sale
Common Stock
2025-10-10$69.25/sh−4,000$277,000→ 13,130 total - Sale
Common Stock
2025-10-10$87.81/sh−8,000$702,480→ 5,130 total
Footnotes (3)
- [F1]Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 10, 2023.
- [F2]The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $86.71 to $88.00. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
- [F3]These stock options are fully vested.